| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 03/05/2003 | CN1399916A Application of dihydromyricetin in preparation of food, cosmetics or medicine |
| 03/04/2003 | US6528490 Plant extracts; free radical scavengers; antiinflammatory agents |
| 02/27/2003 | WO2003016348A2 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
| 02/27/2003 | WO2003015805A1 Composition for removal of toxins |
| 02/27/2003 | WO2003015776A1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 02/27/2003 | WO2003015529A1 A process for tea flower |
| 02/27/2003 | WO2002092588A3 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/27/2003 | WO2001098481A3 Renal regulatory elements and methods of use thereof |
| 02/27/2003 | US20030040512 Pharmaceutical composition with protective action against oxidative/toxic substances, especially cardiotoxic substances |
| 02/27/2003 | US20030040464 Method of treating or preventing attention defecit hyperactivity disorder |
| 02/27/2003 | CA2456843A1 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
| 02/26/2003 | EP1285661A1 Antioxidant and skin preparations for external use |
| 02/26/2003 | EP1284739A1 Composition and method for intervening neuronal death using sulfasalazine |
| 02/26/2003 | EP1284721A2 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes |
| 02/26/2003 | CN1399559A Micro-cluster liquids and methods of making and using them |
| 02/25/2003 | US6525040 4,4-dimethyl-thieno-(3,2-e)-isoselenazine; antioxidants and cytoprotecting |
| 02/25/2003 | US6524834 Protein capable of hydrolyzing organophosphorous acetylcholinesterase inhibitors for use as poison antedote |
| 02/25/2003 | US6524625 Physiologically active extract obtained from indigo plant polygonum tinctorium |
| 02/20/2003 | WO2003013562A1 Artichoke leaf extracts |
| 02/20/2003 | WO2003013513A1 Stable emulsion composition |
| 02/20/2003 | WO2003013268A1 Foodstuff |
| 02/20/2003 | WO2002094980A3 Phytocystatin |
| 02/20/2003 | WO2002085368A3 Use of radical scavenging compounds for treatment and prevention of no-dependent microcirculation disorders |
| 02/20/2003 | WO2002064109A3 Mucoadhesive pharmaceutical formulations |
| 02/20/2003 | US20030035858 Superoxide scavenger and beverage containing such |
| 02/20/2003 | US20030035821 Antioxidant components for reduction of nucleic acid damage in companion animals |
| 02/20/2003 | CA2455761A1 Artichoke leaf extracts |
| 02/20/2003 | CA2455747A1 Foodstuff |
| 02/19/2003 | EP1283869A2 Novel bee venom polypeptides and methods of use thereof |
| 02/19/2003 | EP1283827A2 Caspase inhibitors and uses thereof |
| 02/19/2003 | EP1283713A2 Combined cartilage and plant extract compositions |
| 02/19/2003 | EP1207878B1 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 02/19/2003 | EP0732926B1 Pharmaceutical formulation for preventing or pre-treating poisoning by organophosphoric cholinesterase inhibitors |
| 02/18/2003 | US6521640 Method for interviewing neuronal death using sulfasalazine |
| 02/18/2003 | US6521248 Cavitation; reduced pressure; oxygenated water |
| 02/18/2003 | US6521226 Administering Paraoxonase-1 (PON-1), an expressed protein that has hydrolase activity for organophosphates, and antioxidation activity for low-density lipoprotein (LDL) |
| 02/18/2003 | CA2051520E Use of folic acid and its derivatives for reducing the toxicity of gar-transformylase inhibitors |
| 02/13/2003 | WO2003011899A2 Antigenic polypeptides |
| 02/13/2003 | WO2003011854A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | WO2003011842A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 02/13/2003 | WO2003011339A1 Composition for epigallocatechin gallate |
| 02/13/2003 | WO2003011311A1 Bauhinia extracts |
| 02/13/2003 | WO2003011304A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity |
| 02/13/2003 | WO2003011272A1 Treatment of chronic pain with 3-aryloxy-3-phenylpropanamines |
| 02/13/2003 | WO2003011268A1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 02/13/2003 | WO2003011114A2 Methods for treating prostatitis |
| 02/13/2003 | WO2002081028A3 Cytoprotection by phosphotyrosine |
| 02/13/2003 | US20030032943 Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery |
| 02/13/2003 | US20030032803 Novel amide derivatives as inhibitors of matrix metalloproteinases, TNF-alpha, and aggrecanase |
| 02/13/2003 | US20030032655 Heme oxygenase-1 inducers or induction enhancers |
| 02/13/2003 | US20030032634 Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance |
| 02/13/2003 | CA2808598A1 Antigenic polypeptides |
| 02/13/2003 | CA2753329A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 02/13/2003 | CA2456187A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | CA2453937A1 Antigenic polypeptides |
| 02/13/2003 | CA2453410A1 Methods for treating prostatitis |
| 02/13/2003 | CA2452347A1 Treatment of chronic pain with 3-aryloxy-3-phenylpropanamines |
| 02/12/2003 | EP1282426A1 Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 02/12/2003 | EP1282416A2 Dehydroascorbic acid formulations and uses thereof |
| 02/12/2003 | EP1282414A2 Felbamate derived compounds |
| 02/12/2003 | CN1396823A Electrospun pharmaceutical compositions |
| 02/12/2003 | CN1395967A Grassland locoism toxin vaccine |
| 02/12/2003 | CN1395922A Theopolyphenol composition for injection and its preparing process |
| 02/12/2003 | CN1101221C Traditioal Chinese medicine of clenaing away heat and toxic material, dredging the channel, invigorating yin and yang |
| 02/11/2003 | US6518239 Dry powder compositions having improved dispersivity |
| 02/07/2003 | CA2354743A1 Mitochondrially targeted antioxidants |
| 02/06/2003 | WO2003009843A1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 02/06/2003 | WO2001047946A3 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 02/06/2003 | US20030027764 Novel therapeutic and prophylactic agents and methods of using same |
| 02/06/2003 | US20030027759 Method of using PON-1 to decrease atheroma formation |
| 02/06/2003 | US20030026862 (+)-Cycloolivil as antioxidant obtained from a new natural source namely stereospermum personatum |
| 02/06/2003 | US20030026858 Method for processing ginseng and processed ginseng obtained by the same |
| 02/05/2003 | EP1280816A1 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them |
| 02/05/2003 | EP1280556A1 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 02/05/2003 | EP1280528A2 R-eliprodil for treating glaucoma |
| 02/05/2003 | EP1280526A1 Composition for the prevention and/or treatment, in newborn babies, of the effects of complications during childbirth |
| 02/05/2003 | EP0993433B1 Method for producing calcium pyruvates |
| 02/05/2003 | CN1395574A Food product and producing method |
| 02/05/2003 | CN1395568A 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/05/2003 | CN1100774C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 02/05/2003 | CN1100531C Use of agonists of antagonist of P2 purinoceptors for prevention of glutamate evoked cytotoxicity |
| 02/04/2003 | US6515005 Substituted azole derivatives as inhibitors of corticotropin releasing factor |
| 01/30/2003 | WO2003008533A2 Method for virus propagation |
| 01/30/2003 | WO2003008444A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008443A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008394A1 Novel chelating agents and conjugates thereof, their synthesis and use as diagnostic and therapeutic agents |
| 01/30/2003 | WO2003008371A1 Substituted 4-aminocyclohexanol derivatives |
| 01/30/2003 | WO2003007980A1 Phosphinate-peptide analogues as inhibitors of procollagen-c-proteinase (pcp) for treating fibrotic diseases |
| 01/30/2003 | WO2003007930A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/30/2003 | US20030022863 Antiadhesive carbohydrates |
| 01/30/2003 | US20030022854 Vaccines using nucleic acid-lipid complexes |
| 01/30/2003 | CA2453967A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453965A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453602A1 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/29/2003 | EP1278767A1 Albumin fusion proteins |
| 01/29/2003 | EP1278544A2 Albumin fusion proteins |
| 01/29/2003 | EP1102761B1 Cyclopentabenzofuran derivatives and their use |
| 01/28/2003 | US6511684 Cosmetics or dermitologicals from such as inga bourgoni, goupia glabra or eperua falcate for skin, mucous membranes and/or epithelium |
| 01/28/2003 | US6511675 Dietary supplements |
| 01/23/2003 | WO2003006460A1 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same |